PMN - ProMIS Neurosciences - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

35.73M

Cash

2.529M

Avg Qtr Burn

-4.643M

Short % of Float

0.24%

Insider Ownership

24.33%

Institutional Own.

17.89%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
PMN310 Details Neurodegenerative disease, Alzheimer's disease	Phase 1a Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.